W.G. Shaheen & Associates Dba Whitney & CO Becton Dickinson & CO Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$230.08 - $250.94 $263,901 - $287,828	-1,147 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $639,980 - $705,292	-2,750 Reduced 70.57%	1,147 $282,000
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $3.75 Million - $4.1 Million	-16,104 Reduced 80.52%	3,897 $948,000
Q1 2021 May 11, 2021	SELL	$232.09 - $256.88 $48,738 - $53,944	-210 Reduced 1.04%	20,001 $4.86 Million
Q4 2020 Feb 10, 2021	SELL	$221.92 - $245.94 $430,968 - $477,615	-1,942 Reduced 8.77%	20,211 $5.22 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $39,485 - $50,647	183 Added 0.83%	22,153 $5.16 Million
Q2 2020 Aug 13, 2020	BUY	$219.9 - $263.41 $34,964 - $41,882	159 Added 0.73%	21,970 $5.26 Million
Q1 2020 May 05, 2020	BUY	$195.69 - $279.01 $34,441 - $49,105	176 Added 0.81%	21,811 $5.01 Million
Q4 2019 Feb 06, 2020	BUY	$236.45 - $266.82 $52,491 - $59,234	222 Added 1.04%	21,635 $5.88 Million
Q3 2019 Nov 07, 2019	BUY	$230.58 - $256.08 $223,432 - $248,141	969 Added 4.74%	21,413 $5.58 Million
Q2 2019 Aug 06, 2019	BUY	$217.4 - $246.08 $33,479 - $37,896	154 Added 0.76%	20,444 $5.15 Million
Q1 2019 May 06, 2019	BUY	$206.05 - $248.17 $427,141 - $514,456	2,073 Added 11.38%	20,290 $4.89 Million
Q4 2018 Feb 07, 2019	SELL	$204.73 - $257.93 $461,870 - $581,890	-2,256 Reduced 11.02%	18,217 $4.5 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $4.77 Million - $5.24 Million	20,473 New	20,473 $5.01 Million

Others Institutions Holding BDX

# of Institutions

1,735

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account